Liposomal-Naringenin Radiosensitizes Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro

Background. Naringenin has shown great promise in the realm of cancer therapeutics, demonstrating excellent cytotoxic action toward cancer cells and the enhanced effects of radiation therapy in vitro. However, the medicinal value of naringenin is severely limited clinically by poor bioavailability....

Full description

Saved in:
Bibliographic Details
Main Authors: Keenau Pearce, Samantha I. Cairncross, Mongi Benjeddou
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:IET Nanobiotechnology
Online Access:http://dx.doi.org/10.1049/2024/3786627
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items